Prenatal testing for intellectual disability: misperceptions and reality with lessons from Down syndrome

Area of Science:

• Genetics
• Public Health
• Bioethics

Background:

• Down syndrome is the leading cause of intellectual disability.
• Prenatal screening for Down syndrome is widely recommended in the United States.
• Current policies create a prenatal disadvantage for individuals with Down syndrome.

Purpose of the Study:

• To reconcile the divergent prenatal and postnatal perspectives on Down syndrome.
• To aid parents in making informed decisions about prenatal screening and testing.
• To consider the impact of advancing genetic technologies on informed consent.

Main Methods:

• This study involves a critical review and synthesis of existing literature and policy.
• Analysis of public health recommendations and their impact on perception.
• Exploration of ethical considerations in genetic testing and informed consent.

Main Results:

• Prenatal screening policies create a negative perception and disadvantage for fetuses with Down syndrome.
• Potential advantages for individuals with Down syndrome may exist in the postnatal period.
• Emerging genetic technologies complicate the informed consent process.

Conclusions:

• Reconciling prenatal disadvantages with potential postnatal advantages is crucial for informed decision-making.
• The evolving landscape of genetic testing requires careful consideration of ethical implications and informed consent.
• A balanced perspective is essential to support parents navigating Down syndrome screening and testing.